Stockreport
NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetin...
NKGen Biotech, Inc. (NKGN)
More Company Research
Source: GlobeNewswire
PDF
SNK02 has the potential to be a first-in-class cryopreserved allogeneic NK cell therapy for solid tumors that does not require lymphodepletion before administration, whi
[Read more]
IMPACT SNAPSHOT
EVENT TIME:
{{FirstSection.LastPriceAtNewsEventTime2}}
NKGN
Last Price
{{SecondSection.LastPrice}}
Price Change
{{SecondSection.PriceChange}} {{SecondSection.PriceChangeTriangle_AMP}}
Price Change %
{{SecondSection.PriceChangePercent}} {{SecondSection.PriceChangeTriangle_AMP}}
Volume Shares
{{SecondSection.Volume}}
Max Up
{{SecondSection.MaxUp}}
Max Down
{{SecondSection.MaxDown}}
Volume Ratio
{{SecondSection.VolumeImpactStr_AMP}}%
{{SecondSection.PriceChangePercent}}
Don't Miss Out On The Next BIG Stock Move
{{GreenBoxData.Blurb}}
Performance comparison
Updated
{{SecondSection.VwapEventTime}}
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST PRICE AT
NEWS EVENT {{SecondSection.LastPriceAtNewsEvent}}
|
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
{{FirstSection.LastPrice}}
|
LAST PRICE |
{{SecondSection.LastPrice}}
|
{{FirstSection.VWapStr_AMP}}
{{FirstSection.VwapEventTime}}
|
VWAP |
{{SecondSection.VWapStr_AMP}}
{{SecondSection.VwapEventTime}}
|
{{FirstSection.MaxUp}}
High: {{FirstSection.EodHigh}}
|
MAX UP |
{{SecondSection.MaxUp}}
High: {{SecondSection.EodHigh}}
|
{{FirstSection.MaxDown}}
Low: {{FirstSection.EodLow}}
|
MAX DOWN |
{{SecondSection.MaxDown}}
Low: {{SecondSection.EodLow}}
|
{{FirstSection.TodaysRangeStr_AMP}}
{{FirstSection.RangEvg}}
|
POST NEWS RANGE |
{{SecondSection.TodaysRangeStr_AMP}}
{{SecondSection.RangEvg}}
|
{{FirstSection.PriceChange}}
{{FirstSection.PriceChangeTriangle_AMP}}
|
PRICE CHANGE |
{{SecondSection.PriceChange}}
{{SecondSection.PriceChangeTriangle_AMP}}
|
{{FirstSection.PriceChangePercent}}
|
PRICE CHANGE PERCENTAGE |
{{SecondSection.PriceChangePercent}}
|
{{FirstSection.Spx500}}
|
S&P 500 (SPX) |
{{SecondSection.Spx500}}
|
{{FirstSection.VolumeImpactStr_AMP}}
|
VOLUME RATIO |
{{SecondSection.VolumeImpactStr_AMP}}
|
{{FirstSection.Volume}}
|
VOLUME (SHARES) |
{{SecondSection.Volume}}
|
{{FirstSection.TicksString}}
|
TICKS |
{{SecondSection.TicksString}}
|
{{FirstSection.AvgTransactionSizeStr_AMP}}
|
AVG SHARES PER TRADE |
{{SecondSection.AvgTransactionSizeStr_AMP}}
|
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY